Condition: Nonalcoholic Steatohepatitis

Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)

Protocol I8F-MC-GPHR(a) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)

Location(s): Jacksonville- LaVilla (Downtown)

Condition: Nonalcoholic Steatohepatitis